Nestle

Years after $2B buyout, Nestlé ditches Aimmune's peanut allergy drug Palforzia
Years after $2B buyout, Nestlé ditches Aimmune's peanut allergy drug Palforzia
Fierce Pharma
Nestle
Palforzia
peanut allergy
M&A
Stallergenes Greer
Flag link:
FTC probes Abbott for allegedly colluding on bids for state contracts
FTC probes Abbott for allegedly colluding on bids for state contracts
Medical Marketing and Media
Abbott Labs
Nestle
Reckitt Benckiser
collusion
FTC
state contracts
Flag link:
Nestlé to Sell Off Peanut Allergy Treatment, Not the Blockbuster They Hoped
Nestlé to Sell Off Peanut Allergy Treatment, Not the Blockbuster They Hoped
Motley Fool
Nestle
peanut allergy
Aimmune Therapeutics
Palforzia
Flag link:
Nestlé wagers $41M on Enterome's preclinical food allergy and IBD prospect
Nestlé wagers $41M on Enterome's preclinical food allergy and IBD prospect
Fierce Biotech
Nestle
Enterome
food allergies
IBD
Flag link:
Opportunities arise for once-spurned partners
Opportunities arise for once-spurned partners
EP Vantage
Pfizer
Biohaven
licensing
M&A
Aurinia
Bristol Myers Squibb
AbbVie
Alector
Arcus Biosciences
Biogen
Blueprint Medicines
CureVac
Gilead Sciences
GSK
Incyte
MorphoSys
Roche
Nestle
SAGE Therapeutics
Sarepta Therapeutics
Seres Therapeutics
Syndax
Flag link:
Leaps by Bayer backs a protein engineering startup taking on Aimmune — and Nestlé — in peanut allergy
Leaps by Bayer backs a protein engineering startup taking on Aimmune — and Nestlé — in peanut allergy
Endpoints
Bayer
Aimmune
peanut allergy
Ukko
Nestle
Flag link:
The top 10 largest biopharma M&A deals in 2020
The top 10 largest biopharma M&A deals in 2020
Fierce Pharma
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Gilead Sciences
Forty Seven
Merck
VelosBio
Nestle
Aimmune
Immunomedics
JNJ
Momenta Pharmaceuticals
Sanofi
Principia Biopharma
Bayer
Asklepios BioPharmaeutical
Flag link:
Aimmune Becomes Point Pharmaceutical Business for Nestlé
Aimmune Becomes Point Pharmaceutical Business for Nestlé
BioSpace
Nestle
Aimmune
M&A
food allergies
Flag link:
Gilead rescues biopharma’s takeout scene
Gilead rescues biopharma’s takeout scene
EP Vantage
M&A
Gilead Sciences
Immunomedics
JNJ
Momenta Pharmaceuticals
Sanofi
Principia Biopharma
Nestle
Aimmune
Tizona Therapeutics
Flag link:
The central figure in Nestlé's $2.6B Aimmune buyout? Covid-19
The central figure in Nestlé's $2.6B Aimmune buyout? Covid-19
Endpoints
Nestle
M&A
Aimmune
Palforzia
COVID-19
pandemic
peanut allergy
Flag link:
Nestle pays $2 billion to secure Aimmune’s allergy treatment
Nestle pays $2 billion to secure Aimmune’s allergy treatment
CNBC
Aimmune
Nestle
M&A
peanut allergy
Palforzia
Flag link:
Armed with Nestlé cash, Aimmune grabs experimental food allergy drug form Xencor
Armed with Nestlé cash, Aimmune grabs experimental food allergy drug form Xencor
Fierce Biotech
Aimmune
Xencor
Nestle
AIMab7195
Palforzia
Flag link:
Allergan Offloads Two Drugs to Secure Approval of Merger With AbbVie
Allergan Offloads Two Drugs to Secure Approval of Merger With AbbVie
Xconomy
Allergan
AbbVie
AstraZeneca
M&A
Nestle
Flag link:
Nestlé ups its bet on Aimmune’s peanut allergy drug to $276M as NDA filing looms, rivalry intensifies
Nestlé ups its bet on Aimmune’s peanut allergy drug to $276M as NDA filing looms, rivalry intensifies
Endpoints
Nestle
Aimmune Therapeutics
peanut allergy
Flag link:
Merck KGaA's consumer health sale at risk as Nestle bows out - sources
Merck KGaA's consumer health sale at risk as Nestle bows out - sources
Yahoo/Reuters
consumer health
M&A
Merck KGaA
Nestle
Flag link:
Nestlé determined to acquire Merck KGaA’s Consumer Health unit
Nestlé determined to acquire Merck KGaA’s Consumer Health unit
GoinPharma
Nestle
Merck KGaA
M&A
consumer health
Flag link:
Bayer, its consumer health ambitions snagged, recruits Nestle executive to replace current chief
Bayer, its consumer health ambitions snagged, recruits Nestle executive to replace current chief
Fierce Pharma
Bayer
consumer health
Nestle
Flag link:
Nestle plans to ax hundreds of R&D staffers, shutter big dermatology campus
Nestle plans to ax hundreds of R&D staffers, shutter big dermatology campus
Endpoints
R&D
layoffs
Galderma
Nestle
dermatology
Flag link:
Nestlé’s health science unit inks staged acquisition of Phagesis
Nestlé’s health science unit inks staged acquisition of Phagesis
Mass Device
Nestle
Phagesis
M&A
dysphagia
devices
Flag link:
Embracing biotech, Nestlé recruits AC Immune for an Alzheimer's project
Embracing biotech, Nestlé recruits AC Immune for an Alzheimer's project
Fierce Biotech
Alzheimer's disease
Nestle
AC Immune
R&D
Flag link:

Pages